[Modifiable and non-modifiable risk factors for urolithiasis].
Modifizierbare und nichtmodifizierbare Risikofaktoren für Urolithiasis.
Metaphylaxis
Oxalobacter formigenes
Prevention
Recurrence
Socioeconomic status
Journal
Der Urologe. Ausg. A
ISSN: 1433-0563
Titre abrégé: Urologe A
Pays: Germany
ID NLM: 1304110
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
pubmed:
11
9
2019
medline:
13
11
2019
entrez:
11
9
2019
Statut:
ppublish
Résumé
Knowledge of the risk factors for urolithiasis is the key for sufficient metaphylaxis and reduction of recurrence events. Modifiable risk factors include diet, drink quantity, occupation, environmental factors, number of pregnancies and the intestinal microbiome. The treatment of associated diseases, such as the various manifestations of metabolic syndrome can reduce the risk for urolithiasis and recurrences. Knowledge of non-modifiable risk factors, such as gender, ethnicity, positive family history as well as specific genetic defects and polymorphisms of the calcium and phosphate balance enables personalized counselling and follow-up of affected patients.
Identifiants
pubmed: 31501986
doi: 10.1007/s00120-019-01031-9
pii: 10.1007/s00120-019-01031-9
doi:
Substances chimiques
Calcium Oxalate
2612HC57YE
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
1281-1288Références
J Clin Epidemiol. 1992 Aug;45(8):911-6
pubmed: 1624973
Ann Intern Med. 1997 Apr 1;126(7):497-504
pubmed: 9092314
BMC Health Serv Res. 2016 Jul 18;16:273
pubmed: 27430323
BJU Int. 2018 Mar;121(3):479-485
pubmed: 29235239
J Am Soc Nephrol. 2009 Oct;20(10):2253-9
pubmed: 19679672
Urology. 2018 Aug;118:36-42
pubmed: 29753847
J Am Soc Nephrol. 2014 Feb;25(2):362-9
pubmed: 24335976
J Urol. 2017 Aug;198(2):389-393
pubmed: 28238670
J Urol. 2007 Nov;178(5):1992-7; discussion 1997
pubmed: 17869305
Urolithiasis. 2019 Feb;47(1):23-33
pubmed: 30446806
Am J Kidney Dis. 2018 Jan;71(1):35-41
pubmed: 28823586
J Urol. 2016 Apr;195(4 Pt 1):971-6
pubmed: 26454103
N Engl J Med. 1993 Mar 25;328(12):833-8
pubmed: 8441427
Urology. 2012 Mar;79(3):518-25
pubmed: 22136748
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD004292
pubmed: 22696340
Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1834-1844
pubmed: 27445166
Int J Urol. 2015 Oct;22(10):937-42
pubmed: 26195070
J Urol. 1996 Mar;155(3):839-43
pubmed: 8583588
Kidney Int. 2005 Sep;68(3):1230-5
pubmed: 16105055
Urolithiasis. 2013 Aug;41(4):327-31
pubmed: 23764693
Int J Epidemiol. 1997 Oct;26(5):1017-23
pubmed: 9363523
Kidney Int. 2008 Jan;73(2):207-12
pubmed: 17928824
J Am Soc Nephrol. 2018 Jun;29(6):1731-1740
pubmed: 29748329
Am J Kidney Dis. 2013 Jun;61(6):923-9
pubmed: 23433467
Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S47-51
pubmed: 14681713
Nat Rev Cancer. 2005 May;5(5):388-96
pubmed: 15864280
Adv Urol. 2018 Feb 4;2018:3068365
pubmed: 29515627
J Am Soc Nephrol. 2007 Jul;18(7):2198-204
pubmed: 17538185
J Urol. 2018 Dec;200(6):1273-1277
pubmed: 30059688
Eur J Epidemiol. 2018 Nov;33(11):1033-1047
pubmed: 30066054
Am J Epidemiol. 1996 Feb 1;143(3):240-7
pubmed: 8561157
Urolithiasis. 2019 Feb;47(1):43-56
pubmed: 30460527
Int J Surg. 2016 Dec;36(Pt D):607-612
pubmed: 27847292
Eur J Epidemiol. 2014 May;29(5):363-9
pubmed: 24752465
Clin J Am Soc Nephrol. 2013 Aug;8(8):1389-95
pubmed: 23676355
J Urol. 2013 Oct;190(4):1255-9
pubmed: 23535174
Urolithiasis. 2019 Feb;47(1):11-21
pubmed: 30523390
Urolithiasis. 2019 Feb;47(1):35-42
pubmed: 30673801
Urology. 2010 Aug;76(2):307-13
pubmed: 20138338